<DOC>
	<DOCNO>NCT00056875</DOCNO>
	<brief_summary>This single arm dose escalation study recombinant human keratinocyte growth factor give patient undergo allogeneic bone marrow transplantation high risk graft versus host disease ( GVHD ) .</brief_summary>
	<brief_title>Recombinant Human Keratinocyte Growth Factor Unrelated Related Transplants</brief_title>
	<detailed_description>Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Eligible full intensity bone marrow transplant ( BMT ) condition lack 6/6 HLA idential sibling donor</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>graft versus host disease</keyword>
	<keyword>bone marrow transplant</keyword>
	<keyword>alternative donor</keyword>
</DOC>